WO2026053129 - FERRITIN COMPOSITIONS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/053129
Publication Date
12.03.2026
International Application No.
PCT/IB2025/058874
International Filing Date
03.09.2025
Title **
[English]
FERRITIN COMPOSITIONS AND USES THEREOF
[French]
COMPOSITIONS DE FERRITINE ET LEURS UTILISATIONS
Applicants **
BIOCRAFT PET NUTRITION GMBH
Inventors
SOUKUP, Robert
FALCONER, Shannon Beth
TEWARI, Rupal
HADJISTYLIANOU, Loukia
Priority Data
63/690,241
03.09.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3586 | |
| EPO | Filing, Examination, Granting | 43336 | |
| Japan | Filing, Examination, Granting | 3662 | |
| South Korea | Filing, Examination, Granting | 5015 | |
| USA | Filing, Examination, Granting | 16940 |
Total:
72,539
Contact Us
Abstract[English]
The present disclosure relates to the use of ferritin in lieu of transferrin in culture medium and other compositions or products, such as biomass compositions or cultivated meat compositions. Such compositions or products are suitable for human and/or pet consumption. The invented culture medium is not only able to support long-term growth and culture of animal cells ex vivo but, unlike transferrin-containing culture media, is affordable for both pharmaceutical and food production. The present disclosure also encompasses methods and processes in making and/or manufacturing such cell culture media and/or compositions, as well as their use in products for human and/or pet consumption. The products include for example, food products, feed products, nutraceutical products, and pharmaceutical products.[French]
La présente divulgation concerne l'utilisation de ferritine à la place de la transferrine dans un milieu de culture et d'autres compositions ou produits, tels que des compositions de biomasse ou des compositions de viande cultivée. De telles compositions ou produits sont appropriés pour la consommation humaine et/ou animale. Le milieu de culture de l'invention est non seulement capable de favoriser la croissance à long terme et la culture de cellules animales ex vivo mais, contrairement au milieu de culture contenant de la transferrine, est abordable à la fois pour la production pharmaceutique et alimentaire. La présente divulgation concerne également des procédés et des processus de production et/ou de fabrication de tels compositions et/ou milieux de culture cellulaire, ainsi que leur utilisation dans des produits pour la consommation humaine et/ou animale. Les produits comprennent par exemple des produits alimentaires, des produits alimentaires pour animaux, des produits nutraceutiques et des produits pharmaceutiques.